Detalles de la búsqueda
1.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
N Engl J Med
; 387(20): 1855-1864, 2022 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342163
2.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779348
3.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335828
4.
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
Semin Thromb Hemost
; 50(5): 773-789, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428841
5.
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Eur Heart J
; 44(4): 293-300, 2023 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303404
6.
A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Eur Heart J
; 44(3): 221-231, 2023 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980763
7.
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
Circulation
; 146(15): 1109-1119, 2022 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031810
8.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036760
9.
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study.
Semin Thromb Hemost
; 49(7): 725-735, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868268
10.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587654
11.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587659
12.
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
Circulation
; 143(5): 470-478, 2021 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185476
13.
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE).
Am Heart J
; 251: 61-69, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588897
14.
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Am Heart J
; 243: 147-157, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508693
15.
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
Diabetologia
; 64(6): 1226-1234, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611623
16.
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Circulation
; 142(6): 538-545, 2020 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32551860
17.
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
Circulation
; 141(20): 1600-1607, 2020 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223429
18.
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
J Thromb Thrombolysis
; 51(3): 675-681, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683645
19.
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Circulation
; 140(16): 1308-1317, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31530008
20.
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Circulation
; 139(12): 1483-1492, 2019 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30586750